Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
Cost of Revenue
Bio Rad Laboratories Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bio Rad Laboratories Inc
NYSE:BIO
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cost of Revenue
-$25.8B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
|
Danaher Corp
NYSE:DHR
|
Cost of Revenue
-$18.2B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-7%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cost of Revenue
-$1.5B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Agilent Technologies Inc
NYSE:A
|
Cost of Revenue
-$3.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cost of Revenue
-$9.7B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
See Also
What is Bio Rad Laboratories Inc's Cost of Revenue?
Cost of Revenue
-1.2B
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Cost of Revenue amounts to -1.2B USD.
What is Bio Rad Laboratories Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for Bio Rad Laboratories Inc have been -2% over the past three years , -3% over the past five years , and -2% over the past ten years .